"Carcinoma, Medullary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)
| Descriptor ID |
D018276
|
| MeSH Number(s) |
C04.557.465.625.650.240.315 C04.557.470.200.025.370.315 C04.557.470.615.315 C04.557.580.625.650.240.315
|
| Concept/Terms |
Carcinoma, Medullary- Carcinoma, Medullary
- Carcinomas, Medullary
- Medullary Carcinoma
- Medullary Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Medullary".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Germ Cell and Embryonal [C04.557.465]
- Neuroectodermal Tumors [C04.557.465.625]
- Neuroendocrine Tumors [C04.557.465.625.650]
- Carcinoma, Neuroendocrine [C04.557.465.625.650.240]
- Carcinoma, Medullary [C04.557.465.625.650.240.315]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Neuroendocrine [C04.557.470.200.025.370]
- Carcinoma, Medullary [C04.557.470.200.025.370.315]
- Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
- Carcinoma, Medullary [C04.557.470.615.315]
- Neoplasms, Nerve Tissue [C04.557.580]
- Neuroectodermal Tumors [C04.557.580.625]
- Neuroendocrine Tumors [C04.557.580.625.650]
- Carcinoma, Neuroendocrine [C04.557.580.625.650.240]
- Carcinoma, Medullary [C04.557.580.625.650.240.315]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Medullary".
This graph shows the total number of publications written about "Carcinoma, Medullary" by people in this website by year, and whether "Carcinoma, Medullary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 0 | 3 |
| 1996 | 3 | 3 | 6 |
| 1997 | 2 | 4 | 6 |
| 1998 | 0 | 1 | 1 |
| 1999 | 5 | 0 | 5 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2003 | 5 | 1 | 6 |
| 2004 | 4 | 2 | 6 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 0 | 2 |
| 2007 | 6 | 0 | 6 |
| 2008 | 4 | 0 | 4 |
| 2009 | 8 | 2 | 10 |
| 2010 | 4 | 0 | 4 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 3 | 0 | 3 |
| 2015 | 4 | 0 | 4 |
| 2016 | 3 | 0 | 3 |
| 2017 | 4 | 0 | 4 |
| 2018 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Medullary" by people in Profiles.
-
Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades. J Clin Endocrinol Metab. 2024 Aug 13; 109(9):2256-2268.
-
Radiation Therapy for the Management of Renal Medullary Carcinoma: A Multi-Case Study. Clin Genitourin Cancer. 2024 Jun; 22(3):102065.
-
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance. Nat Commun. 2023 05 26; 14(1):3034.
-
Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy. Clin Transl Med. 2023 05; 13(5):e1267.
-
Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma. Clin Genitourin Cancer. 2021 12; 19(6):e401-e408.
-
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma. Cancer Cell. 2020 05 11; 37(5):720-734.e13.
-
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma. Clin Genitourin Cancer. 2019 02; 17(1):1-6.
-
A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma. Clin Cancer Res. 2018 05 01; 24(9):2044-2049.
-
Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer. Thyroid. 2017 12; 27(12):1523-1533.
-
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib. Clin Cancer Res. 2018 02 15; 24(4):753-765.